ASP Isotopes (ASPI) announced the proposed secondary listing of the Company’s common stock by way of introduction on the Main Board of the Johannesburg Stock Exchange. The Company’s common stock will continue to be listed and traded on the Nasdaq Capital Market. ASPI’s history and technology is firmly rooted in South Africa and has been developed over four years by the Company’s highly skilled South African team members. Furthermore, ASPI has three plants in Pretoria where it is refining the commercial production of Carbon-14, Silicon-28 and Ytterbium-176 to be used across the pharmaceutical, medical, quantum computing and semiconductor industries. ASPI believes that admission to trading of its shares on the JSE will be beneficial to the Company and its stakeholders as it will enhance liquidity for shareholders, diversify the Company’s shareholder base and position ASPI for growth, by providing access to another deep capital market. The listing of ASPI on the JSE is expected to be by way of introduction and to become effective later this year, subject to the necessary regulatory approvals in South Africa.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPI: